Cytori Therapeutics (CYTX) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- S&P 500, Dow futures inch up before inflation data; bank results in focus
- Oil prices surge as Iran deploys new tactics to target tankers
- Bank of America stock falls on earnings miss
- BlackRock earnings beat sends shares higher premarket
- ASML shares climb on raised 2026 outlook, capacity expansion plans
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
GLDG, PGR, CMTL, More
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
GLDG, PGR, CMTL, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackRock earnings beat sends shares higher premarket
- State Street (STT) Tops Q3 EPS by 2c
- Morgan Stanley (MS) Tops Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
